Rare Disease Treatment Market Report

Global and Region Rare Disease Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：205
  • REPORT CODE：GMM995874
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Rare Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Rare Disease Treatmentmarket, defines the market attractiveness level of Rare Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Rare Disease Treatment industry, describes the types of Rare Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rare Disease Treatment market and the development prospects and opportunities of Rare Disease Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rare Disease Treatment market in Chapter 13.

    By Player:

    • Bristol-Myers Squibb Company

    • Novartis AG

    • Pfizer Inc

    • Alexion

    • Amgen, Inc

    • Merck & Co, Inc

    • Johnson & Johnson Services, Inc

    • Vertex Pharmaceuticals

    • Bayer AG

    • Shire

    • Celgene Corporation

    • AbbVie Inc

    • Novo Nordisk A/S

    • Eisai Co Ltd

    • F Hoffmann-La Roche Ltd

    • Teva Pharmaceutical Industries Ltd

    • BioMarin

    • Allergan plc

    • Baxter

    • Sanofi

    By Type:

    • Originator Drugs

    • Generic Drugs

    By End-User:

    • Hospital Pharmacies

    • Specialty Pharmacies

    • Retail Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Rare Disease Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Rare Disease Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Rare Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Rare Disease Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Rare Disease Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Rare Disease Treatment Consumption (2017-2022)

    • 7.2 United States Rare Disease Treatment Consumption (2017-2022)

    • 7.3 Europe Rare Disease Treatment Consumption (2017-2022)

    • 7.4 China Rare Disease Treatment Consumption (2017-2022)

    • 7.5 Japan Rare Disease Treatment Consumption (2017-2022)

    • 7.6 India Rare Disease Treatment Consumption (2017-2022)

    • 7.7 South Korea Rare Disease Treatment Consumption (2017-2022)

    8 Region and Country-wise Rare Disease Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Rare Disease Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Rare Disease Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Rare Disease Treatment Consumption Forecast (2022-2028)

    • 8.4 China Rare Disease Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Rare Disease Treatment Consumption Forecast (2022-2028)

    • 8.6 India Rare Disease Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Rare Disease Treatment Consumption Forecast (2022-2028)

    9 Global Rare Disease Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Rare Disease Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Originator Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Rare Disease Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Specialty Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Rare Disease Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Rare Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Originator Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Rare Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Specialty Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Rare Disease Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Rare Disease Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Rare Disease Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Rare Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Rare Disease Treatment Market Competitive Analysis

    • 14.1 Bristol-Myers Squibb Company

      • 14.1.1 Bristol-Myers Squibb Company Company Details

      • 14.1.2 Bristol-Myers Squibb Company Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol-Myers Squibb Company Rare Disease Treatment Product and Service

    • 14.2 Novartis AG

      • 14.2.1 Novartis AG Company Details

      • 14.2.2 Novartis AG Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis AG Rare Disease Treatment Product and Service

    • 14.3 Pfizer Inc

      • 14.3.1 Pfizer Inc Company Details

      • 14.3.2 Pfizer Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer Inc Rare Disease Treatment Product and Service

    • 14.4 Alexion

      • 14.4.1 Alexion Company Details

      • 14.4.2 Alexion Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Alexion Rare Disease Treatment Product and Service

    • 14.5 Amgen, Inc

      • 14.5.1 Amgen, Inc Company Details

      • 14.5.2 Amgen, Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Amgen, Inc Rare Disease Treatment Product and Service

    • 14.6 Merck & Co, Inc

      • 14.6.1 Merck & Co, Inc Company Details

      • 14.6.2 Merck & Co, Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck & Co, Inc Rare Disease Treatment Product and Service

    • 14.7 Johnson & Johnson Services, Inc

      • 14.7.1 Johnson & Johnson Services, Inc Company Details

      • 14.7.2 Johnson & Johnson Services, Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson & Johnson Services, Inc Rare Disease Treatment Product and Service

    • 14.8 Vertex Pharmaceuticals

      • 14.8.1 Vertex Pharmaceuticals Company Details

      • 14.8.2 Vertex Pharmaceuticals Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Vertex Pharmaceuticals Rare Disease Treatment Product and Service

    • 14.9 Bayer AG

      • 14.9.1 Bayer AG Company Details

      • 14.9.2 Bayer AG Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bayer AG Rare Disease Treatment Product and Service

    • 14.10 Shire

      • 14.10.1 Shire Company Details

      • 14.10.2 Shire Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Shire Rare Disease Treatment Product and Service

    • 14.11 Celgene Corporation

      • 14.11.1 Celgene Corporation Company Details

      • 14.11.2 Celgene Corporation Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Celgene Corporation Rare Disease Treatment Product and Service

    • 14.12 AbbVie Inc

      • 14.12.1 AbbVie Inc Company Details

      • 14.12.2 AbbVie Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AbbVie Inc Rare Disease Treatment Product and Service

    • 14.13 Novo Nordisk A/S

      • 14.13.1 Novo Nordisk A/S Company Details

      • 14.13.2 Novo Nordisk A/S Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Novo Nordisk A/S Rare Disease Treatment Product and Service

    • 14.14 Eisai Co Ltd

      • 14.14.1 Eisai Co Ltd Company Details

      • 14.14.2 Eisai Co Ltd Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Eisai Co Ltd Rare Disease Treatment Product and Service

    • 14.15 F Hoffmann-La Roche Ltd

      • 14.15.1 F Hoffmann-La Roche Ltd Company Details

      • 14.15.2 F Hoffmann-La Roche Ltd Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 F Hoffmann-La Roche Ltd Rare Disease Treatment Product and Service

    • 14.16 Teva Pharmaceutical Industries Ltd

      • 14.16.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.16.2 Teva Pharmaceutical Industries Ltd Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Teva Pharmaceutical Industries Ltd Rare Disease Treatment Product and Service

    • 14.17 BioMarin

      • 14.17.1 BioMarin Company Details

      • 14.17.2 BioMarin Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 BioMarin Rare Disease Treatment Product and Service

    • 14.18 Allergan plc

      • 14.18.1 Allergan plc Company Details

      • 14.18.2 Allergan plc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Allergan plc Rare Disease Treatment Product and Service

    • 14.19 Baxter

      • 14.19.1 Baxter Company Details

      • 14.19.2 Baxter Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Baxter Rare Disease Treatment Product and Service

    • 14.20 Sanofi

      • 14.20.1 Sanofi Company Details

      • 14.20.2 Sanofi Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Sanofi Rare Disease Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Rare Disease Treatment

    • Figure Rare Disease Treatment Picture

    • Table Global Rare Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rare Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rare Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Rare Disease Treatment Consumption by Country (2017-2022)

    • Figure United States Rare Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Rare Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Rare Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Rare Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Rare Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Rare Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Rare Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Rare Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Rare Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Rare Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Rare Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Rare Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Rare Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Originator Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Originator Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Rare Disease Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Rare Disease Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Rare Disease Treatment Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Rare Disease Treatment Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Rare Disease Treatment Product and Service

    • Table Alexion (Foundation Year, Company Profile and etc.)

    • Table Alexion Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Rare Disease Treatment Product and Service

    • Table Amgen, Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen, Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen, Inc Rare Disease Treatment Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Rare Disease Treatment Product and Service

    • Table Johnson & Johnson Services, Inc (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Services, Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Services, Inc Rare Disease Treatment Product and Service

    • Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Vertex Pharmaceuticals Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vertex Pharmaceuticals Rare Disease Treatment Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Rare Disease Treatment Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Rare Disease Treatment Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Rare Disease Treatment Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Rare Disease Treatment Product and Service

    • Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk A/S Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk A/S Rare Disease Treatment Product and Service

    • Table Eisai Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Eisai Co Ltd Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Co Ltd Rare Disease Treatment Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Rare Disease Treatment Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Rare Disease Treatment Product and Service

    • Table BioMarin (Foundation Year, Company Profile and etc.)

    • Table BioMarin Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMarin Rare Disease Treatment Product and Service

    • Table Allergan plc (Foundation Year, Company Profile and etc.)

    • Table Allergan plc Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan plc Rare Disease Treatment Product and Service

    • Table Baxter (Foundation Year, Company Profile and etc.)

    • Table Baxter Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Rare Disease Treatment Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Rare Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Rare Disease Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US